Editorial Commentary: Should “heterogeneous response” be considered as new category for assessing treatment response in patients with breast cancer?

More Info
expand_more

Files

S00259-024-07042-9.pdf
(pdf | 0.88 Mb)
Unknown license
warning

File under embargo until 21-06-2025